Our data indicate that the production of CXCL17 is also highly potentiated during the early stages of pandemic influenza A(H1N1), as the serum levels reported here are as high as those found in other inflammatory and human autoimmune disorders (2, 11). The gene discussed is CXCL17; the disease is Autoimmunity.